Market Cap | 19.20B | P/E | 66.99 | EPS this Y | 14.40% | Ern Qtrly Grth | 22.70% |
Income | 359.3M | Forward P/E | 27.07 | EPS next Y | 11.50% | 50D Avg Chg | 3.00% |
Sales | 3.8B | PEG | 2.59 | EPS past 5Y | 5.74% | 200D Avg Chg | 12.00% |
Dividend | N/A | Price/Book | 2.60 | EPS next 5Y | 11.45% | 52W High Chg | -3.00% |
Recommedations | 2.10 | Quick Ratio | 0.88 | Shares Outstanding | 199.16M | 52W Low Chg | 59.00% |
Insider Own | 0.54% | ROA | 3.39% | Shares Float | 197.91M | Beta | 0.98 |
Inst Own | 98.91% | ROE | 4.65% | Shares Shorted/Prior | 1.93M/2.10M | Price | 387.86 |
Gross Margin | 66.36% | Profit Margin | 9.45% | Avg. Volume | 304,051 | Target Price | 113.15 |
Oper. Margin | 19.20% | Earnings Date | Dec 5 | Volume | 455,518 | Change | -0.55% |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
PETERSMEYER GARY S | Director Director | Jan 04 | Sell | 336.028 | 150 | 50,404 | 2,297 | 01/05/24 |
WEISS ROBERT S | Director Director | Dec 19 | Sell | 365.21 | 79,370 | 28,986,718 | 70,693 | 12/21/23 |
WEISS ROBERT S | Director Director | Dec 19 | Option | 175.31 | 79,370 | 13,914,355 | 150,063 | 12/21/23 |
PETERSMEYER GARY S | Director Director | Dec 14 | Sell | 368.55 | 300 | 110,565 | 2,464 | 12/14/23 |
Ricupati Agostino | SVP & CAO SVP & CAO | Mar 31 | Sell | 370.00 | 1,000 | 370,000 | 863 | 04/03/23 |
WEISS ROBERT S | Director Director | Apr 01 | Option | 0.00 | 693 | 70,693 | 04/03/23 | |
PETERSMEYER GARY S | Director Director | Apr 01 | Option | 0.00 | 630 | 2,764 | 04/03/23 | |
KOZY WILLIAM A | Director Director | Apr 01 | Option | 0.00 | 662 | 6,314 | 04/03/23 | |
Jay Colleen | Director Director | Apr 01 | Option | 0.00 | 630 | 5,977 | 04/03/23 | |
Rivas Maria | Director Director | Apr 01 | Option | 0.00 | 630 | 1,132 | 04/03/23 | |
MADDEN TERESA S | Director Director | Apr 01 | Option | 0.00 | 630 | 1,686 | 04/03/23 | |
Lucchese Cynthia L | Director Director | Apr 01 | Option | 0.00 | 512 | 512 | 04/03/23 | |
PETERSMEYER GARY S | Director Director | Dec 12 | Option | 158.73 | 1,282 | 203,492 | 3,034 | 12/14/22 |
PETERSMEYER GARY S | Director Director | Apr 11 | Sell | 410.55 | 300 | 123,165 | 1,872 | 04/11/22 |
WEISS ROBERT S | Director Director | Apr 01 | Option | 0.00 | 770 | 71,759 | 04/04/22 | |
Lindell Jody S | Director Director | Apr 01 | Option | 0 | 700 | 14,243 | 04/04/22 | |
Lindell Jody S | Director Director | Apr 01 | Sell | 421.04 | 700 | 294,728 | 13,543 | 04/04/22 |
PETERSMEYER GARY S | Director Director | Apr 01 | Option | 0.00 | 700 | 2,172 | 04/04/22 | |
MADDEN TERESA S | Director Director | Apr 01 | Option | 0.00 | 700 | 1,056 | 04/04/22 | |
KOZY WILLIAM A | Director Director | Apr 01 | Option | 0.00 | 735 | 5,652 | 04/04/22 | |
Jay Colleen | Director Director | Apr 01 | Option | 0.00 | 700 | 5,347 | 04/04/22 | |
Rivas Maria | Director Director | Apr 01 | Option | 0.00 | 502 | 502 | 04/04/22 | |
WEISS ROBERT S | Director Director | Mar 29 | Option | 162.28 | 13,039 | 2,115,969 | 76,837 | 03/29/22 |
WEISS ROBERT S | Director Director | Mar 29 | Sell | 416.27 | 13,039 | 5,427,745 | 63,798 | 03/29/22 |
Ricupati Agostino | SVP, Fin & Tax; Chie.. SVP, Fin & Tax; Chief Actg Off | Mar 18 | Option | 211.54 | 5,607 | 1,186,105 | 7,146 | 03/18/22 |
Ricupati Agostino | SVP, Fin & Tax; Chie.. SVP, Fin & Tax; Chief Actg Off | Mar 18 | Sell | 421.53 | 5,607 | 2,363,519 | 1,553 | 03/18/22 |
PETERSMEYER GARY S | Director Director | Sep 15 | Sell | 440.94 | 2,255 | 994,320 | 1,472 | 09/15/21 |
PETERSMEYER GARY S | Director Director | Sep 15 | Option | 158.73 | 1,800 | 285,714 | 300 | 09/15/21 |
Ricupati Agostino | SVP, Fin & Tax; Chie.. SVP, Fin & Tax; Chief Actg Off | Jun 17 | Option | 174.71 | 2,200 | 384,362 | 3,288 | 06/17/21 |
Ricupati Agostino | SVP, Fin & Tax; Chie.. SVP, Fin & Tax; Chief Actg Off | Apr 15 | Option | 156.4 | 1,854 | 289,966 | 2,581 | 04/15/21 |
White Albert G III | President & CEO President & CEO | Mar 08 | Option | 128.22 | 79,745 | 10,224,904 | 121,175 | 03/08/21 |
White Albert G III | President & CEO President & CEO | Mar 08 | Sell | 389 | 79,745 | 31,020,805 | 41,430 | 03/08/21 |
PETERSMEYER GARY S | Director Director | Oct 07 | Option | 162.69 | 1,000 | 162,690 | 2,338 | 10/07/20 |
PETERSMEYER GARY S | Director Director | Oct 07 | Sell | 348.54 | 1,000 | 348,540 | 1,338 | 10/07/20 |